Microparticles mediate hepatic ischemia-reperfusion injury and are the targets of Diannexin (ASP8597).
BACKGROUND & AIMS: Ischemia-reperfusion injury (IRI) can cause hepatic failure after liver surgery or transplantation. IRI causes oxidative stress, which injures sinusoidal endothelial cells (SECs), leading to recruitment and activation of Kupffer cells, platelets and microcirculatory impairment...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC4164362?pdf=render |
| _version_ | 1818174024576925696 |
|---|---|
| author | Narci C Teoh Hussam Ajamieh Heng Jian Wong Kevin Croft Trevor Mori Anthony C Allison Geoffrey C Farrell |
| author_facet | Narci C Teoh Hussam Ajamieh Heng Jian Wong Kevin Croft Trevor Mori Anthony C Allison Geoffrey C Farrell |
| author_sort | Narci C Teoh |
| collection | DOAJ |
| description | BACKGROUND & AIMS: Ischemia-reperfusion injury (IRI) can cause hepatic failure after liver surgery or transplantation. IRI causes oxidative stress, which injures sinusoidal endothelial cells (SECs), leading to recruitment and activation of Kupffer cells, platelets and microcirculatory impairment. We investigated whether injured SECs and other cell types release microparticles during post-ischemic reperfusion, and whether such microparticles have pro-inflammatory, platelet-activating and pro-injurious effects that could contribute to IRI pathogenesis. METHODS: C57BL6 mice underwent 60 min of partial hepatic ischemia followed by 15 min-24 hrs of reperfusion. We collected blood and liver samples, isolated circulating microparticles, and determined protein and lipid content. To establish mechanism for microparticle production, we subjected murine primary hepatocytes to hypoxia-reoxygenation. Because microparticles express everted phosphatidylserine residues that are the target of annexin V, we analyzed the effects of an annexin V-homodimer (Diannexin or ASP8597) on post-ischemia microparticle production and function. RESULTS: Microparticles were detected in the circulation 15-30 min after post-ischemic reperfusion, and contained markers of SECs, platelets, natural killer T cells, and CD8+ cells; 4 hrs later, they contained markers of macrophages. Microparticles contained F2-isoprostanes, indicating oxidative damage to membrane lipids. Injection of mice with TNF-α increased microparticle formation, whereas Diannexin substantially reduced microparticle release and prevented IRI. Hypoxia-re-oxygenation generated microparticles from primary hepatocytes by processes that involved oxidative stress. Exposing cultured hepatocytes to preparations of microparticles isolated from the circulation during IRI caused injury involving mitochondrial membrane permeability transition. Microparticles also activated platelets and induced neutrophil migration in vitro. The inflammatory properties of microparticles involved activation of NF-κB and JNK, increased expression of E-selectin, P-selectin, ICAM-1 and VCAM-1. All these processes were blocked by coating microparticles with Diannexin. CONCLUSIONS: Following hepatic IRI, microparticles circulate and can be taken up by hepatocytes, where they activate signaling pathways that mediate inflammation and hepatocyte injury. Diannexin prevents microparticle formation and subsequent inflammation. |
| first_indexed | 2024-12-11T19:37:49Z |
| format | Article |
| id | doaj.art-dea33627964546ca9ae690a81730c829 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-11T19:37:49Z |
| publishDate | 2014-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-dea33627964546ca9ae690a81730c8292022-12-22T00:53:07ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0199e10437610.1371/journal.pone.0104376Microparticles mediate hepatic ischemia-reperfusion injury and are the targets of Diannexin (ASP8597).Narci C TeohHussam AjamiehHeng Jian WongKevin CroftTrevor MoriAnthony C AllisonGeoffrey C FarrellBACKGROUND & AIMS: Ischemia-reperfusion injury (IRI) can cause hepatic failure after liver surgery or transplantation. IRI causes oxidative stress, which injures sinusoidal endothelial cells (SECs), leading to recruitment and activation of Kupffer cells, platelets and microcirculatory impairment. We investigated whether injured SECs and other cell types release microparticles during post-ischemic reperfusion, and whether such microparticles have pro-inflammatory, platelet-activating and pro-injurious effects that could contribute to IRI pathogenesis. METHODS: C57BL6 mice underwent 60 min of partial hepatic ischemia followed by 15 min-24 hrs of reperfusion. We collected blood and liver samples, isolated circulating microparticles, and determined protein and lipid content. To establish mechanism for microparticle production, we subjected murine primary hepatocytes to hypoxia-reoxygenation. Because microparticles express everted phosphatidylserine residues that are the target of annexin V, we analyzed the effects of an annexin V-homodimer (Diannexin or ASP8597) on post-ischemia microparticle production and function. RESULTS: Microparticles were detected in the circulation 15-30 min after post-ischemic reperfusion, and contained markers of SECs, platelets, natural killer T cells, and CD8+ cells; 4 hrs later, they contained markers of macrophages. Microparticles contained F2-isoprostanes, indicating oxidative damage to membrane lipids. Injection of mice with TNF-α increased microparticle formation, whereas Diannexin substantially reduced microparticle release and prevented IRI. Hypoxia-re-oxygenation generated microparticles from primary hepatocytes by processes that involved oxidative stress. Exposing cultured hepatocytes to preparations of microparticles isolated from the circulation during IRI caused injury involving mitochondrial membrane permeability transition. Microparticles also activated platelets and induced neutrophil migration in vitro. The inflammatory properties of microparticles involved activation of NF-κB and JNK, increased expression of E-selectin, P-selectin, ICAM-1 and VCAM-1. All these processes were blocked by coating microparticles with Diannexin. CONCLUSIONS: Following hepatic IRI, microparticles circulate and can be taken up by hepatocytes, where they activate signaling pathways that mediate inflammation and hepatocyte injury. Diannexin prevents microparticle formation and subsequent inflammation.http://europepmc.org/articles/PMC4164362?pdf=render |
| spellingShingle | Narci C Teoh Hussam Ajamieh Heng Jian Wong Kevin Croft Trevor Mori Anthony C Allison Geoffrey C Farrell Microparticles mediate hepatic ischemia-reperfusion injury and are the targets of Diannexin (ASP8597). PLoS ONE |
| title | Microparticles mediate hepatic ischemia-reperfusion injury and are the targets of Diannexin (ASP8597). |
| title_full | Microparticles mediate hepatic ischemia-reperfusion injury and are the targets of Diannexin (ASP8597). |
| title_fullStr | Microparticles mediate hepatic ischemia-reperfusion injury and are the targets of Diannexin (ASP8597). |
| title_full_unstemmed | Microparticles mediate hepatic ischemia-reperfusion injury and are the targets of Diannexin (ASP8597). |
| title_short | Microparticles mediate hepatic ischemia-reperfusion injury and are the targets of Diannexin (ASP8597). |
| title_sort | microparticles mediate hepatic ischemia reperfusion injury and are the targets of diannexin asp8597 |
| url | http://europepmc.org/articles/PMC4164362?pdf=render |
| work_keys_str_mv | AT narcicteoh microparticlesmediatehepaticischemiareperfusioninjuryandarethetargetsofdiannexinasp8597 AT hussamajamieh microparticlesmediatehepaticischemiareperfusioninjuryandarethetargetsofdiannexinasp8597 AT hengjianwong microparticlesmediatehepaticischemiareperfusioninjuryandarethetargetsofdiannexinasp8597 AT kevincroft microparticlesmediatehepaticischemiareperfusioninjuryandarethetargetsofdiannexinasp8597 AT trevormori microparticlesmediatehepaticischemiareperfusioninjuryandarethetargetsofdiannexinasp8597 AT anthonycallison microparticlesmediatehepaticischemiareperfusioninjuryandarethetargetsofdiannexinasp8597 AT geoffreycfarrell microparticlesmediatehepaticischemiareperfusioninjuryandarethetargetsofdiannexinasp8597 |